Vytrus Biotech, S.A.

BME:VYT Stock Report

Market Cap: €42.9m

Vytrus Biotech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Albert Font

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership17.4%
Management average tenureless than a year
Board average tenureno data

Recent management updates

Recent updates

After Leaping 29% Vytrus Biotech, S.A. (BME:VYT) Shares Are Not Flying Under The Radar

Jul 22
After Leaping 29% Vytrus Biotech, S.A. (BME:VYT) Shares Are Not Flying Under The Radar

Returns Are Gaining Momentum At Vytrus Biotech (BME:VYT)

Apr 29
Returns Are Gaining Momentum At Vytrus Biotech (BME:VYT)

Pinning Down Vytrus Biotech, S.A.'s (BME:VYT) P/E Is Difficult Right Now

Sep 26
Pinning Down Vytrus Biotech, S.A.'s (BME:VYT) P/E Is Difficult Right Now

CEO

Albert Font

no data
Tenure

Mr. Albert Jane is Co-Founder, Member of Management Board, Co-CEO, President & Director at Vytrus Biotech, S.A. and also served as its Chief Operating Officer since 2022 until April 2024. He also served as...

Leadership Team

NamePositionTenureCompensationOwnership
Albert Font
Co-Founderno datano data17.38%
€ 7.5m
Oscar Tarres
Co-Founderno datano datano data
Jordi Martinez
CFO, Member of Management Boardno datano datano data
Daniel Robustillo
Sales Director & Member of Management Boardno datano datano data
Manel Lopez
COO & Member of Management Board1.5yrsno datano data
Sara Laplana
Executive CSO & Member of Management Boardno datano datano data
Gloria Ruiz
Accounting Directorless than a yearno datano data
Alejandro Guirado
Communication & Marketing Managerno datano datano data
Conxita Rusines
ESG & People Wellbeing Manager1.8yrsno datano data
Marta Romero
Finance Controllerless than a yearno datano data
0.9yrs
Average Tenure

Experienced Management: VYT's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/07 00:49
End of Day Share Price 2025/10/07 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Vytrus Biotech, S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Marisa Luisa Mazo FajardoGVC Gaesco Valores